Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2009
10/22/2009US20090263393 Methods of using(+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4 -oxo-1-(2-thiazolyl)- 1,8-naphthyridine-3-carboxylic acid for treatment of cancer
10/22/2009US20090263322 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizines
10/22/2009CA2721595A1 Polymorphs of hydrochloride salt of 5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-n-(1-methylpiperidin-4-yl)-9h-pyrido[2,3-b]indole-7-carboxamide andmethods of use therefor
10/22/2009CA2721467A1 Spirocyclic derivatives as histone deacetylase inhibitors
10/22/2009CA2716886A1 4-[3-(aryloxy)benzylidene]-3-methyl piperidine aryl carboxamide compounds
10/21/2009EP2110377A1 Spirocyclic derivatives as histone deacetylase inhibitors
10/21/2009EP2109611A1 7-azaindole derivatives and their use in the inhibition of c-jun n-terminal kinase
10/21/2009EP2109610A1 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors
10/21/2009EP2040703B1 Derivatives of 2-benzoyl-imidazopyridines, preparation method thereof and use of same in therapeutics
10/21/2009EP1971601B1 N4-phenyl-quinazoline-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
10/21/2009EP1836204B1 Radioactive metal complexes based on bispidine and derivatives thereof
10/21/2009EP1381366B9 Indole, azaindole and related heterocyclic amidopiperazine derivatives
10/21/2009CN101563349A Haloalkyl-substituted pyrimidinone derivatives
10/21/2009CN101563345A Pharmaceutical compounds
10/21/2009CN101563324A Spiro-piperidine derivatives
10/21/2009CN101563323A Spiro-piperidine derivatives
10/21/2009CN101562234A Organic electroluminescent display element
10/21/2009CN101562232A Color-adjustable organic electroluminescent device and preparation method thereof
10/21/2009CN101560213A Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application
10/21/2009CN101560186A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/21/2009CN100551994C Organic electroluminescent devices and metal complex compounds
10/20/2009US7605277 N,N'-Di(1-naphthyl)-N,N'-diphenyl-2,6-diaminodibenzodioxin; organic electroelement hole-transporting layer, light-emitting material, a host materialor dopant in the light-emitting layer,a hole-blocking layer, an electron-transporting layer;high luminous efficiency; high heat resistance; durability
10/20/2009US7605266 Azaindole inhibitors of Aurora kinases
10/20/2009US7605264 Nitrogen-containing tetracylic bridged ring compounds; treating obesity, diabetes and inflammatory or immune associated diseases; nuclear factor kappa beta (NF-KB)
10/20/2009US7605263 Fluorescent naphthalene-1,4,5,8-tetracarboxylic bisimides with an electron-donating substituent on the nucleus
10/20/2009US7605168 PDE4B inhibitors
10/20/2009US7605165 Phenylalanine derivatives
10/20/2009US7605157 Tricyclic tetrahydroquinoline antibacterial agents
10/20/2009US7605111 Herbicides
10/20/2009CA2450122C Novel heterocyclic antibacterial compounds
10/20/2009CA2380852C Tricyclic compounds having spiro union
10/20/2009CA2378183C Antibacterial heterobicyclic substituted phenyl oxazolidinones
10/20/2009CA2376497C Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging
10/20/2009CA2336909C Thiobenzimidazole derivatives which are useful as inhibitors of human chymase activity
10/20/2009CA2214793C Novel intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds
10/15/2009WO2009126861A2 Triazolopyridine compounds useful as dgat1 inhibitors
10/15/2009WO2009126635A1 2-amino-benzothiazole derivates useful as inhibitors of rock kinases
10/15/2009WO2009126584A1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
10/15/2009WO2009126530A2 Cgrp receptor antagonists
10/15/2009WO2009126514A1 Compounds and compositions as kinase inhibitors
10/15/2009WO2009126203A1 N-type semiconductor materials in thin film transistors
10/15/2009WO2009126123A1 Bicyclic nitrogen containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors
10/15/2009WO2009125809A1 Piperidine derivatives
10/15/2009WO2009125808A1 Aminocyclohexyl derivative
10/15/2009WO2009125425A2 Improved process for the preparation of (s.s)-2.8-diazabicyclo[4.3.0]nonane
10/15/2009WO2009124692A1 New substituted spiro[cycloalkyl-1,3'-indol]-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors.
10/15/2009WO2009124627A1 Fluorine derivatives for organic electroluminescence devices
10/15/2009WO2009086123A8 Imidazo [1,2-a] pyridine compounds
10/15/2009WO2009065920A3 Compounds
10/15/2009WO2009016460A8 Pyrazole compounds and their use as raf inhibitors
10/15/2009US20090259043 Tricyclic cytoprotective compounds
10/15/2009US20090258922 Compound exhibiting pgd2 receptor antagonist
10/15/2009US20090258897 Substituted benzimidazoles
10/15/2009US20090258894 Fused Aminopiperidines as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
10/15/2009US20090258893 Fused quinoline derivative and use thereof
10/15/2009US20090258884 Substituted amides
10/15/2009US20090258877 Triazolotriazines and triazolopyrazines and their use
10/15/2009US20090258874 Pyrazolo-heteroaryl compounds
10/15/2009US20090258868 Heterocyclic aspartyl protease inhibitors
10/15/2009US20090258866 CGRP Receptor Antagonists
10/15/2009US20090258861 Tetrahydronaphthyridine Derivatives
10/15/2009US20090258856 Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
10/15/2009CA2719650A1 Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors
10/15/2009CA2719538A1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
10/14/2009EP2108641A1 New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
10/14/2009EP2108362A2 Method of producing a cationic liposomal preparation comprising a lipophilic compound
10/14/2009EP2108018A2 8-oxa-1,4-diazaspiro [4,5] dec-3-en-1-yl and 1,4,8-triazaspiro [4,5] dec-3-en-1-yl acetamides as glyti transporter inhibitors in treatment of neurological and neuropsychiatric disorders
10/14/2009EP2108017A2 Imidazolone compounds as tgf-beta family type i receptors, alk5 and/or alk4 antagonists
10/14/2009EP1833830B1 Quinoline derivative, use and production thereof, and drug containing the same
10/14/2009EP1786774B1 Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
10/14/2009EP1720829B1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
10/14/2009EP1599476B1 Novel diazabicyclic aryl derivatives
10/14/2009EP1461337B1 Pyrido¬2,1-a isoquinoline derivatives as dpp-iv inhibitors
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009EP1337527B1 Indolylmaleimide derivatives as protein kinase c inhibitors
10/14/2009CN101558069A Cis-cyclohexyl substituted pyrimidinone derivatives
10/14/2009CN101558068A Phenylacetamides useful as protein kinase inhibitors
10/14/2009CN101558067A 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as MTOR inhibitors
10/14/2009CN101558062A Indolylmaleimide derivatives as kinase inhibitors
10/14/2009CN101558050A Non-nucleoside reverse transcriptase inhibitors
10/14/2009CN101558030A Condensed ring aromatic compound for organic light-emitting device and organic light-emitting device having the same
10/14/2009CN101555248A Method for preparing poly-substituted 1, 5-naphthyridine compound
10/14/2009CN101555247A Pyrazol[3,4-b]quinoline compound containing trifluoromethyl and synthesizing method thereof
10/14/2009CN100549012C Aryl- and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of FAAH enzyme inhibitors
10/14/2009CN100549011C Novel imidazopyridines as cyclin dependent kinase inhibitors
10/14/2009CN100549004C Spirocyclic heterocyclic derivatives and methods of their use
10/14/2009CN100548990C Processes for preparing benzo[b]thiophene derivatives
10/14/2009CN100548296C Mitotic kinesin inhibitors
10/13/2009US7601840 Carboline derivatives useful in the inhibition of angiogenesis
10/13/2009US7601839 Pyrrolo-pyridine kinase modulators
10/13/2009US7601838 2[-2,5 dichlorobenzenesulfonyl]-1,2,3,4,-tetrahydro-9H-pyrido[3,4-b]indole-3-carboxylic acid methyl ester; for intravascular thrombosis such as myocardial ischemia and stroke
10/13/2009US7601836 Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
10/13/2009US7601737 Isotopically substituted proton pump inhibitors
10/13/2009US7601736 Pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same
10/13/2009US7601735 Antiviral compounds
10/13/2009US7601734 Cyclic amine compound
10/13/2009US7601713 Kinase inhibitors and their uses
10/13/2009US7601337 Delivery of antipsychotics through an inhalation route
10/13/2009CA2521846C Reverse-turn mimetics and method relating thereto
10/13/2009CA2455298C Condensed polycyclic compounds
1 ... 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 ... 646